Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Back DiMarchi, Richard, email to Lara Marks, 8 April 2025
Update to Management of Hyperglycemia in T2D: A Consensus Report by the ADA and the European Association for the Study of Diabetes The ADA and the European Association for the Study of Diabetes (EASD) also revised their joint consensus on the management of hyperglycemia in T2D in 2018
The takeaway: Compounded pharmacies offer more affordable options for GLP-1 drugs, but there are increased risks that result in a "buyer-beware" market
Its GLP-1 menu spans injectable compounded semaglutide, sublingual semaglutide, oral tirzepatide, injectable liraglutide, and oral phentermine
Study limitations and funding source Professor Tuttle's study used data from the FLOW (Evaluate Renal Function with Semaglutide Once Weekly) trial, which is funded by pharmaceutical company Novo Nordisk
